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ABSTRACT 
As one of the major organs, the liver plays vital roles in the homeostasis of an individual. 
Being able to identify master regulator genes, genes whose product can affect the activation or 
deactivation of other genes, will enrich our understanding of hepatic function and liver disease. 
Previously, our lab used genome-wide microarray data to identify several transcription factors 
that may play a key role in liver expression. Here we ask whether overexpression of these 
transcription factors in a non-liver cell would result in liver phenotype activation or general 
disruption of gene regulation. To this end, we stably introduced seven transcription factors that 
we identified as being liver-specific into a non-liver cell line, followed by whole-genome 
expression analysis. As controls, we introduced a neo-plasmid to monitor general plasmid 
effects, as well as the HNF la gene, previously shown to rescue liver-specific gene expression. 
Results show that introduction of the neo-plasmid alone resulted in 9 genes activated and 58 
genes repressed by 2:2.5 fold. Overexpression of transcription factors resulted in between 320 
and 664 genes activated, and 158 and 348 genes repressed by 2:2.5 fold even after controlling for 
the neo-plasmid data. In some cases, we observed much overlap. For example, 41 genes were 
activated by 4 of the 4 transcription factors (HHEX, CREG, CREB, and HNF6), with CREG and 
CREB sharing activation of an additional 94 genes. Focusing on only hepatic genes, each of the 
transcription factors activated between 13 and 35 liver-specific genes. However, there was little 
overlap between which genes that were activated in each case. These results suggest that while 
over-expression of transcription factors may activate tissue-specific genes, there is also a general 
dysregulation of gene expression that must be considered when interpreting data. 
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1. INTRODUCTION 
Hepatocytes primarily regulate mRNA production of liver-specific genes through 
transcription factors ( 1-2). Several mechanisms of gene regulation have been proposed in the 
literature (3). HNFla and HNF4a were demonstrated to regulate each other by binding to the 
other's promoter region (4). Both of these factors have been shown to partially rescue the 
hepatic phenotype, and HNF4 may prevent HNFI from being deactivated (4-6). HNF6 has also 
been shown to promote HNF4a (5). Another transcription factor, XBP I, was also found to 
regulate lipid synthesis in the liver (6). 
Throughout the literature, variant cells derived from rat hepatomas have been used to 
better understand liver metabolism and gene regulation (7-11). Some of these studies test for the 
activation of alpha-1-antritrypisin (SER PINA I), which is highly expressed in hepatic tissues. 
Several transcription factors were previously identified as candidates of master regulation 
in rat liver tumor cells: HNF I a, HNF6, IGFBP I, HHEX, CREB, WNT4, and CREG ( 12). Our 
lab uses a system of comparing expression levels of liver-specific genes from rat liver tumor 
cells (F g I 4 ), ''variant'" cells that have lost the hepatic phenotype (H 11 ), and transfected variant 
cells (Figure I). 
Our lab demonstrated partial rescue of the hepatic phenotype in HNFla transfected cells. 
HNF4a demonstrated a regulatory pathway with HNF I a via mutual binding to the other's 
promoter site. However, the use of RT-qPCR is limited to a small gene pool due to the 
impracticalities of applying this method to wide-scale analysis. Therefore, in order to understand 
how these transcription factors affect the cell as a whole, our lab sent RNA samples to the 
University of Illinois at their Urbana-Champaign location to perform a microarray analysis ( 12). 
By testing the effects of the five other candidate master regulators (CREG, CREB, IGFBP I, 
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HHEX, and HNF6) on the variant cell line and comparing to the hepatoma, non-transfected 
variant as well as the HNF 1 a transfected variant, we can determine whether the transcription 
factors are targeting tissue-specific genes or producing general disruption of the genome. 
The WNT4 gene, another potential master regulator, assists in sexual development. Loss 
of function in this gene can cause SERKAL syndrome, which results in sex reversal (13). 
Current literature suggests that WNT4 has a significant role in the development of other tissues 
such as lung (14) and kidney (15). If WNT4 is lowly expressed in muscle tissue, there tends to be 
a lack of acetylcholine receptors, while overexpression causes an increase (16). Since WNT4 
seems to influence various tissues, it is an interesting candidate for study on hepatic gene 
regulation. 
Our lab's main objectives were to determine whether overexpression of transcription 
factors produces a liver-specific effect or a general disruption by comparing microarray data of 
transfected variant cells to hepatoma, non-transfected variants, and the HNF 1 a transfected 
variant line that demonstrated partial rescue of hepatic function. To do this, we compared the 
numbers and overlap of activated genes from each transfected cell line in the entire genome and 
in only genes upregulated by the hepatoma cell line. In addition, we also determined the tissue 
specificity of affected genes by each of the transcription factors and compared them to HNF 1 a. 
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2. MATERIALS & METHODS 
2.1 Cell Lines and Culture Conditions 
Cell lines used for the microarray analysis and transfections descended from H41 IEC3, a 
rat liver tumor cell line. The cell type used as the benchmark for liver phenotype, Fgl4, is 
adenine phosphoribosyltransferase-positive and xanthine-guanine phosphoribosyltransferase­
positive. Fgl 4  cell types were collected from APRT- and hypoxanthine-guanine 
phosphoribosyltransferase-negative (HPRT-) Fado-2 cells being transfected stably with Gpt and 
Aprt trans genes under the influence of human SERPINA 1 gene promoter (-640 to -2 bp). Cells 
that appear to have lost liver phenotype, H 11, are descendants of the Fg 14 cell type. H 11 were 
negatively selected against the Aprt and Gpt expression using 20 mg/mL of 2,5-diaminopurine 
(OAP) and 30 mg/mL 6-thioxanthine, respectively. H I  1 regain hepatic phenotype at a 10-3 
frequency. Cells were grown in I: 1 Ham's F 12/Dulbecco's modified Eagle's medium (FDV) 
with 5% fetal bovine serum (FBS) (Gibco) and 5 µg/ I 00 mL penicillin-streptomycin (Gibo) 
unless otherwise stated. Cells were incubated at 3 7°C in a humid 5% C02 chamber. 
2.2 Transfection of HJ 1 with Transcription Factors 
For each well, with a total of three wells (A, 8, and C) of a 6-well plate, 1,000,000 H 11 
cells were plated in 5 mL of growing medium. Cells were counted using a hemocytometer. The 
next day cells were transfected using Lipofectamine L TX and Plus Reagent from Invitrogen 
(Thermo Fisher Scientific, Carlsbad, CA). The cells were then incubated for 48 hours. 
Slides were prepared for the GFP-transfected H 11 P cells and observed under UV light. 
Both the control and the transfected H 11 cells were split each into five T-25 flasks in 5 mL of 
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selective G4 l 8 media. These flasks were monitored over the course of the next few weeks to 
allow growth of the transfected clones. 
2.3 RNA Isolation & cDNA Synthesis 
Once the transfected cells had reached a high density on I 00 mm plates, RNA was 
isolated using the RNAeasy Plus Mini Kit (Qiagen, Hilden, Germany). Using the High Capacity 
cDNA Reverse Transcription Kit by Appliedbiosystems (Thermo Fisher Scientific), the isolated 
RNA was used to synthesize cDNA. The cDNA samples were diluted by a factor of ten for RT­
pCR. 
2.4 Real-Time quantitative Polymerase Chain Reaction 
Diluted cDNA samples were used to perform Real-Time quantitative Polymerase Chain 
Reactions (RT-qPCR). Reactions were performed using PowerUp SYBR Green Master Mix by 
Appliedbiosystems (Thermo Fisher Scientific, Austin, TX). Each tube contained I 0 µI SYBR 
Green, 2 µL of diluted cDNA (replaced by nuclease-free water in the control), I µL each of 
forward and reverse primer (2 µL total), and 6 µL of nuclease-free water. Three tubes were used 
for each cDNA. Depending on the primers being tested, the annealing temperature was either 
60°C or 64°C. GAPDH primers were used to correct the results of liver-specific genes. 
2.5 Illumina Microarray Analysis 
The lllumina microarray analysis was performed by the W.M. Keck Center for 
Comparative and Functional Genomics in the Roy J. Carver Biotechnology Center at the 
University of Illinois at Urbana-Champaign. The quality of RNA was tested using the Agilent 
2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA). Using the lllumina Total Prep RNA 
Amplification Kit (Ambion, Inc., Austin, TX), single-stranded cDNA was synthesized via 
reverse transcription with an oligo(dT) primer containing a T7 promoter and 300 ng of high-
7 
quality RNA. The single-stranded cDNA was synthesized into double-stranded cDNA and 
purified. The cDNA was then used as a template for a 14-hour in vitro transcription (IVT) 
reaction. The cRNA was purified using the same kit. After testing for quality, a 16-hour 
hybridization to the RatRef-12 v 1 Expression Bead Chips (Illumina, Inc., San Diego, CA) was 
performed in the 58°C Hybridization Oven using 750 ng of cRNA. The next steps of washing, 
staining using streptavidin-Cy3 (GE Healthcare Bio-Sciences, Piscataway, NJ), and scanning 
were completed via instructions in the Illumina Whole-Genome Gene Expression Direct 
Hybridization Assay Guide (Part#l 1322355, Rev. A). For each of the two BeadChips, 12 arrays 
were performed, which were scanned using an Illumina BeadArray Reader. All 24 arrays were 
screened to detect signal artifacts, scratches, or debris. Images were analyzed using the 
Gene Expression Module (version 1.8.0) of the Illumina Genome Studio software. 
2.5 Analysis of Data 
All data were controlled for plasmid effects using the neo plasmid. Genes were sorted 
based on their upregulation and downregulation in the transfected cell line when compared to 
non-transfected H 11. Genes were also sorted based on which transcription factors affected them 
by at least 2.5-fold. Specificity of genes were pulled from Genecards. 
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3. RESULTS 
To address the possibility of genomic instability that could be caused by overexpression 
of transcription factors, I analyzed whole genome expression profiles in the hepatoma variant 
cell line, H 11. Cells were transfected with a series of genes encoding transcription factors 
identified in a genomic screen comparing expression profiles of hepatoma cells (Fgl4) to 
hepatoma variant cells (HI I cells) (12). Genes transfected included HNFI, HNF6, CREB, 
CREG, IGFBP I and HHEX. Each gene was in an expression vector that included the neo gene to 
allow for G4 l 8 selection of transfectants. 
I compared the expression profile of the Fg 14 hepatoma cells to that of H 11 cells to 
identify the number genes differentially expressed. Fg 14 cells expressed 554 genes at levels 2::2.5 
fold higher than the H 11 cells. Surprisingly, the Fg 14 cells also expressed 357 genes at 2::2.5 fold 
lower levels that the H 11 cells. 
In order to control for effects of the plasmid alone, pKOneo, a plasmid expressing only 
the neo gene, was used. Results showed only a small number of genes (9) were activated 2::2.5 
fold, although a much larger number (58) were repressed by 2::2.5 due introduction of the neo 
plasmid. In contrast, H 11 cells transfected with the transcription factor plasmids showed 2::2.5 
fold activation of between 75 and 664 genes (Figure 2A). IGFBP I had the highest number of 
activated genes (664). Excluding neo-effects, only two transcription factors had activated less 
than 100 genes: HNF!a (76 genes) and HHEX (68 genes). Conversely, between 76 and 215 
genes were repressed by at least 2.5 fold with CREG being the highest and HNFI being the 
lowest (Figure 28). In the case of HHEX, CREG, CREB, and HNF6, 41 genes were activated by 
all four transcription factors out of the I 099 total genes activated by all transcription factors. 
(Figure 3). 
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To determine the effects overexpression had on genes that were highly upregulated in 
hepatoma, I only considered genes expressed 2":2.5 fold in the FgI4 cells compared to the HI I.  
With this limited pool of genes, I4 to 42 genes were upregulated by at  least 2.5 fold (Figure 4A). 
HNFia had the highest number, while HNF6 had the lowest. CREB, CREG, IGFBPI, and 
HHEX upregulated 35, 23, 29, and 27 genes. Between 4 to 25 genes were repressed by 2":2.5 fold. 
CREG repressed the most, while CREB and HNFia both had the lowest (Figure 4B). Very little 
overlap was observed between HN FI, HHEX, CREB, and CREG, especially HNF I (Figure 5). 
Similarly, I analyzed possible patterns in genes that were downregulated in hepatoma and 
subsequently considered only genes that were downregulated 2":2.5 fold by FgI4 compared to 
HI I cells. Between I to I 0 genes were upregulated 2":2.5 fold, HNF I a being the highest and 
HHEX being the lowest (Figure 6A). Between I 9 to 72 were repressed 2":2.5 fold, with HNF6 
being the lowest and CREG being the highest (Figure 6B). 
To understand the activated gene profile due to overexpression of the transcription 
factors, I compared the tissue-specificity of genes activated in each of the transfected cell lines 
when genes were expressed 2":2.5 fold relative to the non-transfected HI I cell line. The results 
revealed that I 7% of genes activated by 2":2.5 fold in HI I- HNF I a were either liver specific or 
selective for liver (Figure 7 A). For the other five cell lines, the highest was 6% in HI 1-HHEX 
(Figure 7B) and HI I-CREB (Figure 7C). When only considering genes upregulated 2":2.5 fold by 
FgI4 compared to HI I, 4I% of genes activated 2":2.5 fold in HI I- HNFia were either liver 
specific or selective for liver (Figure 8A). HHEX had the next highest percentage (18%) (Figure 
8B), while CREG had the lowest (4%) (Figure 8C). 
I next asked whether another candidate gene, Wnt4, identified in our analysis could 
rescue hepatoma gene expression in the H 11 cells. To this end, a Wnt4 expression vector was 
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introduced into the H 11 cells, G4 I 8 selected, and pooled clones were expanded and analyzed 
using RT-qPCR. The HI l -WNT4 pool cells were tested for overexpression of the transfected 
human WNT4 gene and found to express high levels compared to the H 11 cells (results not 
shown). I then tested for effects on a panel of other liver genes. High expression of the liver­
specific genes SERPINA I (average cycle number 23.26), KNG I (average cycle number 21.88), 
and FGB I (average cycle number 22.99) was observed. However, the non-transfected H 11 cells 
also showed the same high expression levels (average cycle numbers 20.67, 22. I 2, and 22.75). 
Importantly, both of these cell lines had higher expression levels than the hepatoma (average 
cycle numbers 23 .26, 28.24, and 26.51) (Figure 9), suggesting that the HI I cells were 
contaminated. 
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3 .  DISCUSSION 
Each of the transcription factors, except for HNF 1 a, had high numbers of genes being 
either activated or repressed by �2.5 fold. In both cases, HNF 1 had numbers below 100. 
Similarly, HHEX also activated less than 100 genes. Notably, HHEX deactivated 108 genes, 
while the next highest number was 129 from CREB. When looking only at genes upregulated 
�2.5 fold by F g 14 in comparison to H 11, HNF I a was the highest at 42 genes. Most of the other 
transcription factors, however, were comparable to HNF 1 a except for HNF6. Despite high 
numbers in genome-wide activation, CREB had low gene repression in this category. Genes that 
were repressed in F g 14 compared to H 11 revealed that HN F 1 a activated the most genes 
compared to other transcription factors. This suggests that HNF 1 a is upregulating genes that are 
downregulated in hepatoma despite previously being found to positively regulate liver-specific 
genes. Furthermore, HNF la did not have the highest number of genes repressed in this category. 
Instead, CREB repressed 44 more genes than HNFla. In general, HNFla behaved like a liver 
master regulator. Although not strongly, both HHEX and CREB seemed to show that they may 
regulate hepatic function. 
Figure 2 demonstrates that these transcription factors do not share many genes. For 
example, when considering HHEX, HNF6, CREB, and CREG, there was a large portion of 
overlap, but many genes were only affected by one transcription factor. CREB activated 284 
genes that none of the other transcription factors significantly affected. In addition, when only 
looking at genes that were also upregulated by Fg 14, this pattern persisted. HNF 1 a, the gene that 
partially rescues the hepatic phenotype, overlaped very little with CREB, CREG, and HHEX. If 
these were liver master regulators, large overlap would have likely occurred. These genes would 
be affecting a similar pool and therefore share many genes. However, it would be unlikely that 
12 
any one gene would affect the entire hepatic phenotype. Instead, this responsibility would likely 
be divided among several genes such that, while one transcription factor might regulate one part 
of the hepatic phenotype, a different factor would control another part. 
Genome-wide analysis showed that genes activated by HNF 1 a had large portions 
dedicated to liver. The other transcription factors did not appear to have this same trend, which 
suggests that they may not have large roles in liver function. When looking at genes upregulated 
in Fgl 4, HNFla again showed large portions dedicated to liver. The other transcription factors 
did not show this strong activation. However, HHEX and CREB still had noticeable activation. 
For the strange case of the WNT4 expression profiles, it is likely that before transfection 
these H 11 were either contaminated by F g 14 or were actually F g 14 that were mislabeled as H 11. 




As expected, overexpression of HNF I a did seem to follow trends that were expected of 
hepatic gene regulators. In some areas there were unexpected results, such as having a high 
activation of hepatoma-downregulated genes. This suggests that one should give these 
transcription factors leniency when analyzing genome-wide studies. In general, none of the other 
transcription factors showed a strong pattern that followed HNF I a. In addition, there was little 
overlap between HNFl a and the other transcription factors. Out of these five, HHEX and CREB 
appeared to be the strongest candidates for hepatic gene regulators. When using RT-qPCR to 
monitor expression of tissue-specific genes, a genome-wide analysis should also be considered. 
Many of these transcription factors seemed to be producing general effects rather than targeting 
liver-specific tissues. Further studies should exercise caution when studying expression levels of 
genes affected by overexpression of transcription factors, as these results may be caused by cell 
disruption rather than targeted regulation. In order to determine WNT4's role in hepatic function, 








Non�epatnma Hepatoma rescue?? 
Figure 1. Rat liver hepatoma cells underwent a selection mechanism where non-hepatoma H 11 
cells were identified. H 11 cells were transfected with transcription factors to determine if said 
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Figure 2. Genomic-wide upregulation of �2.5 fold (A) or repression of�2.5 fold (B) by each 
transcription factor transfected into the H 11 cell line. 
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Figure 3. Venn diagram of shared genes activated �2.5 fold across the genome of H 11 cells 
transfected with HHEX, CREB, CREG, or HNF6. Transfected cells were compared to non­
transfected H 11 to determine expression differences. 
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Figure 4. Number of genes that were activated (A) or repressed (B) by 2:.2.5 fold with 
transcription factors transfected into the H 11 cell line relative to non-transfected H 11 cells. Only 
genes activated 2:.2.5 fold in Fg 14 compared to H 11 cells were considered. 
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Figure 5. Figure 3. Venn diagram of shared genes activated �2.5 fold across the genome of HI I 
cells transfected with HHEX, CREB, CREG, or HNF I .  Transfected cells were compared to non­
transfected H I  I to determine expression differences. Only genes upregulated in Fgl 4 cells by 
�2.5 fold compared to H 11 were considered. 
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Figure 5. Number of genes that were activated (A) or repressed (B) by 2:2.5 fold with 
transcription factors transfected into the H l  1 cell line relative to non-transfected H 11 cells. Only 
genes repressed 2.5 fold in Fg 14 compared to H 11 cells were considered. 
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Figure 7. Genome-wide expression of genes activated 2'.:2.5 fold by HNF I a (A), HHEX (B), 
CREB (C), CREG (D), IGFBPI (E), and HNF6 (F) when transfected into H I  1 cells compared to 
non-transfected H 11 cells. 
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Figure 8. Tissue specificity of genes upregulated 2'.:2.5 fold in HNFla (A), HHEX (B), CREB 
(C), CREG (0), IGFBPl (E), and HNF6 (0) when transfected into Hl l cells compared to non­
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Figure 9. Fgl4, Hl 1, and HI l-WNT4 Pool cycle numbers when tested for SERPfNAl, KNGl, 
and FGB I. A lower cycle number is a higher expression level. 
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